Chronic myeloid leukemia (CML) is driven by the BCR-ABL fusion oncoprotein [102], which is involved, among other pathways, in the transcriptional regulation of STAT3 [103,104] and STAT5 [105,106]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.